Octavio Espinoza, Chief Financial Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 5,000 shares at $115.03 ($575K) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Open-market sale of $575k LGND by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LGND | SELL | 2026-03-06 | $5.5M | — | Filing → |
| LGND | SELL | 2025-12-16 | $679K | — | Filing → |
| LGND | BUY | 2025-05-13 | $156K | — | Filing → |